Cong Chen
Impact in
- Nephrology top 2%
- Gout, Hyperuricemia, Uric Acid
- Dermatology top 1%
- Cutaneous lymphoproliferative disorders research
Papers in
- Immunology 43
- Reproductive System and Pregnancy 11
- Immune Cell Function and Interaction 9
- Immune cells in cancer 7
- Oncology 32
- Cancer Immunotherapy and Biomarkers 8
- Co-authors
- Justin L. Ricker (6 shared papers)Stanley R. Frankel (2 shared papers)Madeleine Duvic (4 shared papers)Elise A. Olsen (4 shared papers)Sareeta R. S. Parker (4 shared papers)Theresa R. Pacheco (4 shared papers)Timothy Michael Kuzel (2 shared papers)Jean Marie Arduino (2 shared papers)
- Journals
- Scientific Reports (4 papers)Frontiers in Cardiovascular Medicine (4 papers)Frontiers in Pharmacology (4 papers)Advanced Science (3 papers)Investigational New Drugs (3 papers)
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Cong Chen
181 papers receiving 5.1k citations
Cong Chen's Hit Papers
Peers
Comparison fields: 5 of 163
- Nephrology 338
- Dermatology 387
- Immunology 826
- Cancer Research 514
- Oncology 926
Countries citing papers authored by Cong Chen
This map shows the geographic impact of Cong Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cong Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cong Chen more than expected).
Fields of papers citing papers by Cong Chen
This network shows the impact of papers produced by Cong Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cong Chen. The network helps show where Cong Chen may publish in the future.
Co-authors
The 25 scholars most cited alongside Cong Chen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 188 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase IIB Multicenter Trial of Vorinostat in Patients With Persistent, Progressive, or Treatment Refractory Cutaneous T-Cell Lymphoma Hit paper breakdown → | 2007 | 844 |
| 2 | 2004 | 382 | |
| 3 | 2012 | 270 | |
| 4 | Naringenin attenuates non‐alcoholic fatty liver disease by down‐regulating the NLRP3/NF‐κB pathway in mice Hit paper breakdown → | 2019 | 256 |
| 5 | 2012 | 255 | |
| 6 | 2007 | 153 | |
| 7 | 2008 | 153 | |
| 8 | 2019 | 137 | |
| 9 | 2019 | 121 | |
| 10 | 2018 | 90 | |
| 11 | 2017 | 89 | |
| 12 | 2019 | 81 | |
| 13 | 2009 | 77 | |
| 14 | 2017 | 74 | |
| 15 | 2021 | 68 | |
| 16 | 2015 | 61 | |
| 17 | 2018 | 56 | |
| 18 | 2017 | 55 | |
| 19 | 2016 | 53 | |
| 20 | 2011 | 51 |
About Cong Chen
Cong Chen is a scholar working on Immunology, Oncology, Molecular Biology, Epidemiology and Cancer Research, having authored 188 papers that have together received 5.2k indexed citations. Recurring topics across this work include Reproductive System and Pregnancy (11 papers), Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (8 papers), RNA modifications and cancer (8 papers), Autophagy in Disease and Therapy (7 papers), Histone Deacetylase Inhibitors Research (7 papers), Immune cells in cancer (7 papers) and Cancer-related gene regulation (6 papers). The work is most often cited by research in Nephrology (338 citations), Dermatology (387 citations), Immunology (826 citations), Cancer Research (514 citations) and Oncology (926 citations). Cong Chen has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Justin L. Ricker, Stanley R. Frankel, Madeleine Duvic, Elise A. Olsen, Sareeta R. S. Parker, Theresa R. Pacheco, Timothy Michael Kuzel, Jean Marie Arduino, Youn H. Kim and Francine M. Foss. Their work appears in journals such as Scientific Reports, Frontiers in Cardiovascular Medicine, Frontiers in Pharmacology, Advanced Science and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.